RAC 0.28% $1.80 race oncology ltd

Ann: Bisantrene Shows Broad Anti-Cancer Activity in Cancer Cells, page-6

  1. 4,820 Posts.
    lightbulb Created with Sketch. 1087
    Good to get some news we have all been craving but it feels a bit…so what and that we are back where we were years ago.

    Still pre clinical and today we find out Bisantrene has the “potential” to treat many lines of cancer either in isolation or combination with Doxi…yes right and what’s new?

    Luckily the BoD are looking into ways to use this info in future clinical trials still to be planned and executed…and are also looks at “ways” to commercialise and maximise SH value from
    this discovery!!! Hope they do a better job than they have with FTO and Cardio Protection….

    Sorry for the negative post but it feels like we have gone a long way back and are just fannying around rather than having a laser focus on progressing what we already knew years ago.
 
watchlist Created with Sketch. Add RAC (ASX) to my watchlist
(20min delay)
Last
$1.80
Change
-0.005(0.28%)
Mkt cap ! $306.5M
Open High Low Value Volume
$1.81 $1.83 $1.80 $99.50K 55.11K

Buyers (Bids)

No. Vol. Price($)
2 7942 $1.80
 

Sellers (Offers)

Price($) Vol. No.
$1.81 1500 1
View Market Depth
Last trade - 14.48pm 28/06/2024 (20 minute delay) ?
RAC (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.